What is the recommended treatment and dosage for Maalox (aluminum hydroxide, magnesium hydroxide) for patients with heartburn, indigestion, or upset stomach?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 1, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Maalox for Heartburn, Indigestion, and Upset Stomach

Recommended Treatment and Dosage

Maalox (aluminum hydroxide and magnesium hydroxide) can be used as adjunctive therapy for breakthrough symptoms in patients with heartburn and indigestion, but proton pump inhibitors (PPIs) are the preferred first-line treatment for sustained symptom control. 1

Role of Maalox in Acid Peptic Disease Management

As Adjunctive Therapy

  • Maalox should be used primarily for breakthrough symptoms rather than as monotherapy for chronic heartburn or GERD. 1
  • Alginate-containing antacids (which may include Maalox formulations) can be added to PPI therapy for regurgitation-predominant symptoms. 1
  • Antacids provide rapid symptom relief but have short duration of action compared to acid-suppressive medications. 2

Historical Maintenance Dosing

  • In older studies, Maalox TC at 3 tablets twice daily (162 mmol total daily) was as effective as cimetidine 400 mg at bedtime for preventing duodenal ulcer relapse. 3
  • Maalox TC at 3 tablets at bedtime alone (81 mmol) was less effective than twice-daily dosing. 3
  • However, these dosing regimens are now superseded by more effective PPI therapy as first-line treatment. 1

First-Line Treatment Approach (Not Maalox)

Initial Management

  • Begin with a standard-dose PPI once daily, taken 30-60 minutes before a meal, for 4-8 weeks. 1, 2
  • Any commercially available PPI (omeprazole, lansoprazole, pantoprazole, rabeprazole, esomeprazole, dexlansoprazole) is appropriate. 1
  • PPIs are more effective than H2-receptor antagonists, which are more effective than antacids alone. 2, 1

Treatment Escalation

  • If symptoms persist after 4-8 weeks of once-daily PPI, increase to twice-daily dosing before meals. 1, 2
  • At this stage, Maalox can be added for breakthrough symptoms between PPI doses. 1

Specific Clinical Scenarios for Maalox Use

On-Demand Rapid Relief

  • For patients requiring immediate symptom relief, antacids like Maalox are the most rapidly acting agents. 2
  • The efficacy can be sustained by combining antacids with an H2-receptor antagonist or PPI. 2

Gastritis or Reflux Symptoms

  • Maalox demonstrated high symptomatic efficacy in treating duodenal ulcer (25 patients), gastric ulcer (14 patients), erosive gastroduodenitis (14 patients), and erosive reflux-esophagitis (9 patients) in older studies. 4
  • However, current guidelines prioritize PPIs over antacids for these conditions. 1

Important Drug Interactions

Critical Caveat with Antibiotics

  • Maalox significantly reduces absorption of certain antibiotics, particularly fluoroquinolones. 5
  • When trovafloxacin was given 30 minutes after Maalox, bioavailability was reduced by 66%. 5
  • If antibiotics are prescribed, separate Maalox administration by at least 2 hours before the antibiotic dose. 5

Safety Considerations

Adverse Effects

  • Diarrhea is the most common side effect, occurring in approximately 10-12% of patients on regular Maalox therapy. 3
  • Serum aluminum concentrations may increase with chronic use but typically remain within acceptable ranges. 3
  • Serum magnesium concentrations generally remain unchanged with regular use. 3

When to Avoid Empiric Antacid Therapy

  • Patients with alarm symptoms (dysphagia, bleeding, anemia, weight loss, recurrent vomiting) require immediate endoscopic evaluation, not empiric antacid therapy. 1
  • Patients with symptoms unresponsive to twice-daily PPI therapy for 8 weeks need endoscopy and objective reflux testing, not escalation to higher-dose antacids. 1, 2

Common Pitfalls to Avoid

  • Do not use Maalox as monotherapy for chronic GERD or peptic ulcer disease when PPIs are indicated. 1
  • Do not continue empiric antacid therapy long-term without confirming the diagnosis in patients who don't respond adequately. 1
  • Do not administer Maalox concurrently with fluoroquinolone antibiotics or other medications requiring acidic environment for absorption. 5
  • Do not confuse heartburn with dyspepsia; consider proton pump inhibitors or H2 blockers for patients who have difficulty discriminating heartburn from nausea. 2

References

Guideline

Initial Treatment for Acid Peptic Disease

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Effect of Maalox and omeprazole on the bioavailability of trovafloxacin.

The Journal of antimicrobial chemotherapy, 1997

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.